Eli Lilly LLY Income Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| $72.25B+10.8% | $65.18B+9.7% | $59.42B+11.6% | $53.26B+8.7% | $49B+8.8% | ||
| $12.4B+12.2% | $11.05B+9.6% | $10.08B+9.1% | $9.25B+3.1% | $8.97B+6.6% | ||
| $59.84B+10.6% | $54.13B+9.7% | $49.34B+12.1% | $44.01B+9.9% | $40.03B+9.3% | ||
| 82.8%-0.2pp | 83%0.0pp | 83%+0.4pp | 82.6%+0.9pp | 81.7%+0.4pp | ||
| $14.11B+5.8% | $13.34B+6.2% | $12.56B+6.2% | $11.83B+5.6% | $11.2B+1.9% | ||
| $11.56B+4.2% | $11.09B+6.8% | $10.39B+6.6% | $9.75B+7.0% | $9.11B+6.0% | ||
| -$397M+30.5% | -$571M+0.4% | -$573.2M-51.6% | -$378.1M+22.1% | -$485.1M-122% | ||
| $31.13B+21.0% | $25.73B+14.3% | $22.5B+33.5% | $16.86B+24.0% | $13.6B+7.3% | ||
| $5.85B+14.9% | $5.09B+24.4% | $4.09B+33.7% | $3.06B+22.7% | $2.49B+19.3% | ||
| $25.28B+22.5% | $20.64B+12.1% | $18.41B+33.4% | $13.8B+24.3% | $11.11B+4.9% | ||
| 35%+3.3pp | 31.7%+0.7pp | 31%+5.1pp | 25.9%+3.2pp | 22.7%-0.8pp | ||
| $28.15+22.7% | $22.95+12.3% | $20.44+33.6% | $15.30+24.5% | $12.29+5.0% | ||
| $33.17B+19.6% | $27.73B+13.6% | $24.4B+30.1% | $18.75B+21.5% | $15.43B+6.8% | ||
| 45.9%+3.4pp | 42.5%+1.5pp | 41.1%+5.9pp | 35.2%+3.7pp | 31.5%-0.6pp | ||
| $31.13B+21.0% | $25.73B+14.3% | $22.5B+33.5% | $16.86B+24.0% | $13.6B+7.3% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What is Eli Lilly's revenue?
- Eli Lilly (LLY) generated $72.2B in revenue over the trailing twelve months, up 47.4% year over year.
- Is Eli Lilly profitable?
- Eli Lilly reported $25.3B in net income over the trailing twelve months, a 35.0% net margin.
- What is Eli Lilly's earnings per share?
- Eli Lilly's diluted EPS over the trailing twelve months is $28.15.
- Where does Eli Lilly's income statement data come from?
- Every line is extracted from Eli Lilly's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
